--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q140.560M / 11.667M--
Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
ZNTL Zentalis Pharmaceuticals
- 2.915
- -0.215-6.87%
Close Dec 18 16:00 ET
- 2.930
- +0.015+0.51%
Pre 08:00 ET
207.74MMarket Cap-1.17P/E (TTM)
3.220High2.810Low1.47MVolume3.170Open3.130Pre Close4.35MTurnover2.86%Turnover RatioLossP/E (Static)71.27MShares18.07052wk High0.59P/B150.48MFloat Cap2.66052wk Low--Dividend TTM51.62MShs Float87.190Historical High--Div YieldTTM13.10%Amplitude2.660Historical Low2.953Avg Price1Lot Size
Zentalis Pharmaceuticals Key Stats
Zentalis Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Zentalis Pharmaceuticals Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data